FDA Slams Beckman for Selling 'Adulterated,' 'Misbranded' Access AccuTnI Troponin Test

The news comes two months after Beckman said it would remove the AccuTnI troponin test kits from use with the company's UniCel DxI system after notifying customers that a positive bias could lead to elevated AccuTnI results.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.